Literature DB >> 27018280

Secreted growth differentiation factor 15 as a potential biomarker for mitochondrial dysfunctions in aging and age-related disorders.

Yasunori Fujita1, Yu Taniguchi2, Shoji Shinkai2, Masashi Tanaka3, Masafumi Ito1.   

Abstract

We and other have recently shown that growth differentiation factor 15 (GDF15) is a useful diagnostic marker for mitochondrial diseases, which are inherited disorders caused by mitochondrial or nuclear genomic mutations that lead to impaired energy production. As the primary cause of mitochondrial diseases is mitochondrial dysfunction, the blood level of GDF15 might reflect mitochondrial function in patients, and thus could be a marker for mitochondrial dysfunction. GDF15 has been implicated in aging and various age-related disorders, such as cardiovascular diseases and diabetes, the blood level of which is reportedly elevated in older adults as well as in patients. Although GDF15 might be induced as a result of various cellular stresses and dysfunctions, it would also be possible that the blood GDF15 level reflects at least in part mitochondrial dysfunction in aging and age-related disorders. In the present review, we summarized the current literature regarding GDF15 in aging and age-related disorders from the perspective of biomarkers, with a particular focus on mitochondrial dysfunction.
© 2016 Japan Geriatrics Society.

Entities:  

Keywords:  age-related disorders; aging; biomarker; growth differentiation factor 15; mitochondrial dysfunction

Mesh:

Substances:

Year:  2016        PMID: 27018280     DOI: 10.1111/ggi.12724

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  59 in total

1.  Expression of lipogenic markers is decreased in subcutaneous adipose tissue and adipocytes of older women and is negatively linked to GDF15 expression.

Authors:  Veronika Šrámková; Michal Koc; Eva Krauzová; Jana Kračmerová; Michaela Šiklová; Moustafa Elkalaf; Dominique Langin; Vladimír Štich; Lenka Rossmeislová
Journal:  J Physiol Biochem       Date:  2019-03-25       Impact factor: 4.158

2.  Growth differentiation factor-15 as a biomarker of strength and recovery in survivors of acute respiratory failure.

Authors:  Brian J Rosenberg; Michio Hirano; Catarina M Quinzii; Elizabeth Colantuoni; Dale M Needham; David J Lederer; Matthew R Baldwin
Journal:  Thorax       Date:  2019-09-18       Impact factor: 9.139

3.  Growth and differentiation factor 15 is secreted by skeletal muscle during exercise and promotes lipolysis in humans.

Authors:  Claire Laurens; Anisha Parmar; Enda Murphy; Deborah Carper; Benjamin Lair; Pauline Maes; Julie Vion; Nathalie Boulet; Coralie Fontaine; Marie Marquès; Dominique Larrouy; Isabelle Harant; Claire Thalamas; Emilie Montastier; Sylvie Caspar-Bauguil; Virginie Bourlier; Geneviève Tavernier; Jean-Louis Grolleau; Anne Bouloumié; Dominique Langin; Nathalie Viguerie; Fabrice Bertile; Stéphane Blanc; Isabelle de Glisezinski; Donal O'Gorman; Cedric Moro
Journal:  JCI Insight       Date:  2020-03-26

4.  Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.

Authors:  Xinbo Ji; Lizhen Zhao; Kunqian Ji; Yuying Zhao; Wei Li; Rui Zhang; Ying Hou; Jianqiang Lu; Chuanzhu Yan
Journal:  Mol Neurobiol       Date:  2016-11-26       Impact factor: 5.590

Review 5.  Motoric cognitive risk syndrome: Integration of two early harbingers of dementia in older adults.

Authors:  Richard D Semba; Qu Tian; Michelle C Carlson; Qian-Li Xue; Luigi Ferrucci
Journal:  Ageing Res Rev       Date:  2020-01-26       Impact factor: 10.895

6.  Elevated Plasma Growth and Differentiation Factor 15 Is Associated With Slower Gait Speed and Lower Physical Performance in Healthy Community-Dwelling Adults.

Authors:  Richard D Semba; Marta Gonzalez-Freire; Toshiko Tanaka; Angelique Biancotto; Pingbo Zhang; Michelle Shardell; Ruin Moaddel; Luigi Ferrucci
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2020-01-01       Impact factor: 6.053

7.  A Novel Model of Diabetic Complications: Adipocyte Mitochondrial Dysfunction Triggers Massive β-Cell Hyperplasia.

Authors:  Christine M Kusminski; Alexandra L Ghaben; Thomas S Morley; Ricardo J Samms; Andrew C Adams; Yu An; Joshua A Johnson; Nolwenn Joffin; Toshiharu Onodera; Clair Crewe; William L Holland; Ruth Gordillo; Philipp E Scherer
Journal:  Diabetes       Date:  2019-12-27       Impact factor: 9.461

Review 8.  GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease.

Authors:  Dongdong Wang; Emily A Day; Logan K Townsend; Djordje Djordjevic; Sebastian Beck Jørgensen; Gregory R Steinberg
Journal:  Nat Rev Endocrinol       Date:  2021-08-11       Impact factor: 43.330

9.  Unique Human and Mouse β-Cell Senescence-Associated Secretory Phenotype (SASP) Reveal Conserved Signaling Pathways and Heterogeneous Factors.

Authors:  Ayush Midha; Hui Pan; Cristian Abarca; Joshua Andle; Priscila Carapeto; Susan Bonner-Weir; Cristina Aguayo-Mazzucato
Journal:  Diabetes       Date:  2021-03-05       Impact factor: 9.461

10.  International Workshop:: Outcome measures and clinical trial readiness in primary mitochondrial myopathies in children and adults. Consensus recommendations. 16-18 November 2016, Rome, Italy.

Authors:  Michelangelo Mancuso; Robert McFarland; Thomas Klopstock; Michio Hirano
Journal:  Neuromuscul Disord       Date:  2017-09-08       Impact factor: 4.296

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.